Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
01/07/1999 | EP0888323A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
01/07/1999 | EP0888316A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
01/07/1999 | EP0888307A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |
01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
01/07/1999 | EP0724592B1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
01/07/1999 | DE19829229A1 Hydrazinderivate Hydrazine |
01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
01/07/1999 | CA2293565A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy |
01/07/1999 | CA2291734A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
01/06/1999 | CN1204327A Pharmaceutically active quinazoline compounds |
01/06/1999 | CN1204320A Alpha-substituted arylsulphonamido hydroxamic acids as TNF-alpha and matrix metalloproteinase inhibitors |
01/06/1999 | CN1204261A Pharmaceutical compositions of macrolides or cyclosporine with polyethoxylated saturated hydroxy-fatty acid |
01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
01/06/1999 | CN1203793A Artificial tiger-bone and its producing process and use |
01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
01/06/1999 | CN1041520C Quinoline or quinazoline derivatives, their production and use |
01/05/1999 | US5856446 Method of treating rheumatoid arthritis with low dose type II collagen |
01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
01/05/1999 | US5856358 Prevent bone erosion |
01/05/1999 | US5856354 Tachykinin antagonists |
01/05/1999 | US5856345 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen |
01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
01/05/1999 | US5856325 Reducing inflammation by inhibiting pla2 in a mammal |
01/05/1999 | US5856323 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
01/05/1999 | US5856314 Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
01/05/1999 | US5856305 Inflammatory rheumatoid arthritis |
01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
01/05/1999 | US5856169 Isolated nucleic acid |
01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
01/05/1999 | CA2157117C Spirocyclic piperidine derivatives |
01/05/1999 | CA2152919C Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
01/03/1999 | CA2236462A1 Murc |
01/01/1999 | CA2236459A1 Novel compounds |
01/01/1999 | CA2236441A1 Gida2 |
01/01/1999 | CA2236425A1 Gida1 |
01/01/1999 | CA2235785A1 Serine/threonine protein kinase (h-sgk2) |
12/30/1998 | WO1998058964A1 Methods and compositions for galactosylated glycoproteins |
12/30/1998 | WO1998058938A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
12/30/1998 | WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
12/30/1998 | WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
12/30/1998 | WO1998058678A1 Anti-cd40l immunotoxins for the treatment of diseases |
12/30/1998 | WO1998058664A1 Use of proteolytic enzymes for treating septic shock |
12/30/1998 | WO1998058652A1 Stable aspirin ointment preparations |
12/30/1998 | WO1998058651A1 Stable aspirin-containing preparations for external use |
12/30/1998 | WO1998058641A1 Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
12/30/1998 | EP0887416A2 Human AFC1 |
12/30/1998 | EP0887415A2 Human RCE1 |
12/30/1998 | EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor |
12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
12/30/1998 | EP0887347A1 Process for the preparation of dry thioctic acid |
12/30/1998 | EP0887081A2 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/30/1998 | EP0760661B1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
12/30/1998 | EP0705258B1 Azolyl-cyclic amine derivatives with immunomodulatory activity |
12/30/1998 | EP0618889B1 Tri-substituted phenyl derivatives and processes for their preparation |
12/30/1998 | CN1203602A Acylated enol derivatives of 'alpha'-ketoesters and 'alpha'-ketoamides |
12/30/1998 | CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
12/30/1998 | CN1203589A New compound |
12/30/1998 | CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate |
12/30/1998 | CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
12/30/1998 | CA2264022A1 Stable aspirin-containing preparations for external use |
12/29/1998 | US5854412 Chemokine N-terminal deletion mutations |
12/29/1998 | US5854289 Guanylhydrazones and their use to treat inflammatory conditions |
12/29/1998 | US5854257 Naphthyridinone derivatives |
12/29/1998 | US5854256 Quinuclidine derivatives |
12/29/1998 | US5854239 Diazabicyclic neuokinin antagonists |
12/29/1998 | US5854234 Amidino dervatives useful as nitric oxide synthase inhibitors |
12/29/1998 | US5853997 Human protein phosphatase |
12/29/1998 | US5853732 Pharmaceutical compositions containing kukui nut oil |
12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
12/29/1998 | CA2153050C Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
12/27/1998 | CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease |
12/24/1998 | DE19726248A1 Verwendung proteolytischer Enzyme zur Behandlung von septischem Schock The use of proteolytic enzymes in the treatment of septic shock |
12/24/1998 | DE19725615A1 Zur topischen Applikation bestimmte Diclofenac-Lösung For topical application specific diclofenac solution |
12/24/1998 | DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists |
12/24/1998 | CA2234418A1 Human afc1 |
12/24/1998 | CA2234402A1 Human rce1 |
12/23/1998 | WO1998058066A1 New human lysophospholipase |
12/23/1998 | WO1998057991A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | WO1998057987A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
12/23/1998 | WO1998057980A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | WO1998057979A1 Peptides and compounds that bind to the il-5 receptor |
12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
12/23/1998 | WO1998057972A1 Quaternary ammonium compounds as tachykinin antagonists |
12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
12/23/1998 | WO1998057954A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
12/23/1998 | WO1998057939A1 Crystalline roxifiban |
12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
12/23/1998 | WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
12/23/1998 | WO1998057624A1 Diclofenac solution for topical application |
12/23/1998 | WO1998038985A3 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |